Simcere Pharmaceutical Group COVID-19 Drug Gets Chinese Regulator's Marketing Approval
Simcere Pharmaceutical Group COVID-19 Drug Gets Chinese Regulator's Marketing Approval
中化集團生產的COVID-19藥品獲得了中國監管機構的市場批准
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊